Cancer is a general term that encompasses different subtypes of abnormal cellular growth in different areas of the body. One such type of cancer is the uncontrollable proliferation of skin cells known ...

In a recent study published in JAMA, researchers evaluated the efficacy and safety of zilebesiran doses in reducing mild to moderate hypertension. Study: RNA Interference With Zilebesiran for Mild to ...

A particular protein deficiency that leads to liver and lung damage is currently treatable only with decades-old therapies that all have limitations. Biotech startup AIRNA is part of a field of ...

Renowned molecular biologist Yunsun Nam, Ph.D., Professor in the Departments of Biochemistry and Biophysics and the Doris and Bryan Wildenthal Distinguished Chair in Medical Science at UT Southwestern ...

Nearly 1.3 billion adults around the world have clinically high blood pressure, many of whom may be unaware that they are living with this condition. Nearly 1.3 billion adults around the world have ...

RNA therapies are emerging as a promising treatment for cancer, but some types of the disease don’t respond well to it. Now, scientists at Tel Aviv University have demonstrated a way to use RNA drugs ...

Cow’s milk contains nanoparticles that can be used to deliver disease-modifying RNA therapy orally, according to a new study. With RNA-based drugs currently only administrable by injection, the ...

Explore the potential of gene therapy as a groundbreaking approach to curing diseases, beyond traditional pharmacological ...

A developer of RNA editing therapies whose lead program targets Alpha-1 antitrypsin deficiency (AATD) said today it has closed an oversubscribed $60 million Series A financing, with plans that include ...

Lipid-based nanoparticles are a popular research area as a non-viral platform for delivering RNA molecules and include liposomes, lipoplexes, lipid nanoparticles and solid lipid nanoparticles. Using ...